M Von Euler

Biography

Mikael held global clinical responsibility for the HER family of compounds including Herceptin, Pertuzumab and Tarceva, and acted as a Cluster Head for the HER2 Franchise. Prior to Roche, Mikael was Vice President, Oncology MDC, Europe, at GlaxoSmithKline and worked across several key clinical development roles at AstraZeneca..  Mikael held global clinical responsibility for the HER family of compounds including Herceptin, Pertuzumab and Tarceva, and acted as a Cluster Head for the HER2 Franchise. Prior to Roche, Mikael was Vice President, Oncology MDC, Europe, at GlaxoSmithKline and worked across several key clinical development roles at AstraZeneca.. 

Research Interest

Pharmaceutics